The board of directors of Alphamab Oncology (Company) announced that Mr. QIU Yu Min ('Mr. Qiu') has tendered his resignation from the position as a non-executive Director with effect from June 16, 2022 due to his other work commitments. Following Mr. Qiu's resignation as a non-executive Director, he ceased to be a member of the audit committee of the Company. The Board announced that, Dr. GUO Zijian, an independent non-executive Director, has been appointed as a member of the Audit Committee with effect from June 16, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 HKD | +5.65% | -44.96% | -60.54% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.54% | 306M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+38.14% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- Alphamab Oncology Announces Board and Committee Changes